Two-dimensional (2D) perovskites are increasingly recognized as promising candidate materials for the next generation of ...

Implementation sits outside Part D, with Humana handling PA, adjudication, and reimbursement; manufacturers provide a $245 net price for Wegovy, Zepbound, and orforglipron. Eligibility requires PA and ...

At the moment, RevMed remains keenly focused on its mission to bring daraxonrasib to the masses and continue developing new medicines that target RAS. (Darren Incorvaia) This year’s meeting of the ...

The construction of the Gordie Howe International Bridge and its customs plazas in Detroit and Windsor is nearing completion, setting the stage for a potential standoff with President Donald Trump ...

The Trump administration, which took a noninterventionist approach to artificial intelligence, is now discussing imposing oversight on A.I. models before they are made publicly available. By Tripp ...

The bridge program operates outside of the Part D plan's usual payment flow, so insurers do not have to opt in and will not carry risk for drugs furnished under the model, CMS said on its website.

AACR was full of biotechs showcasing their preclinical Ras candidates, including Clasp Therapeutics, Verastem Oncology and BlossomHill Therapeutics. (Darren Incorvaia) After dropping headline-grabbing ...

PARIS — RAS Luxury Skincare, the Indian farm-to-face brand, closed a 65 Crores, or $7.5 million, Series B funding round led by Dabur Ventures. Dabur Ventures is the venture arm of the largest ...

Gordie Howe International Bridge photos in May 2024. (Windsor-Detroit Bridge Authority (WDBA)) DETROIT – President Donald Trump threatened to block the opening of the newly constructed Gordie Howe ...

The era of size inclusivity is seemingly over. Our critic traces the shift and hopes designers might learn from it. By Vanessa Friedman I know models have always been skinny, but it seems to me they ...

Spinal deformities such as scoliosis and kyphosis are among the most serious complications of neurofibromatosis type 1 (NF1), a genetic disorder that affects about one in 3,000 people. These ...